*LILLY TO BUY AJAX THERAPEUTICS FOR UP TO $2.3B IN CASH (priv)
*LIGAND PHARMACEUTICALS TO BUY XOMA AT $39/SHARE VALUE: WSJ (no pr yet)
*RE/MAX NEARS SALE TO TECH-FOCUSED REAL-ESTATE FIRM: WSJ (given the pro-forma % reax will own, this may largely be a stock deal w a cash kiss, that’s why it’s “low” /but not totally wrong/ right now)